Lenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC) Meeting Abstract
| Authors: | Makker, V.; Taylor, M. H.; Aghajanian, C.; Oaknin, A.; Mier, J.; Cohn, A. L.; Romeo Marin, M.; Bratos Lorenzo, R.; Brose, M. S.; DiSimone, C.; Messing, M. J.; Stepan, D. E.; Dutcus, C. E.; Wu, J.; Schmidt, E. V.; Orlowski, R. J.; Sachdev, P.; Shumaker, R.; Casado Herraez, A. |
| Abstract Title: | Lenvatinib (LEN) and pembrolizumab (PEMBRO) in advanced endometrial cancer (EC) |
| Meeting Title: | 44th ESMO Congress (ESMO 2019) |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2019 Sep 27-Oct 1 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-10-01 |
| Start Page: | mdz250.002 |
| Language: | English |
| ACCESSION: | WOS:000491295503043 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz250.002 |
| Notes: | Meeting Abstract: 994O -- Appears on pages v404-v405 of the abstract book -- Source: Wos |
